The store will not work correctly when cookies are disabled.
3-benzyl-5-(4-chlorophenyl)-2-thioxo-1H-thieno[2,3-d]pyrimidin-4-one
ID: ALA4571346
Cas Number: 379236-99-4
PubChem CID: 1047836
Max Phase: Preclinical
Molecular Formula: C19H13ClN2OS2
Molecular Weight: 384.91
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=c1c2c(-c3ccc(Cl)cc3)csc2[nH]c(=S)n1Cc1ccccc1
Standard InChI: InChI=1S/C19H13ClN2OS2/c20-14-8-6-13(7-9-14)15-11-25-17-16(15)18(23)22(19(24)21-17)10-12-4-2-1-3-5-12/h1-9,11H,10H2,(H,21,24)
Standard InChI Key: ILKYRSSTSHMXTC-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
3.7559 -5.2447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4636 -4.8331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1755 -5.2447 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.1755 -6.0597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4636 -6.4713 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.7559 -6.0597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9583 -6.3113 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.4889 -5.6610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9802 -4.9993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7682 -4.2077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9765 -3.9953 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7665 -3.2068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3464 -2.6311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1330 -2.8394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3472 -3.6286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1344 -1.8395 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
5.8832 -6.4713 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.8832 -4.8331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5910 -5.2447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2990 -4.8334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0073 -5.2442 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0073 -6.0595 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3016 -6.4702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5910 -6.0648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4636 -4.0140 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
3 2 1 0
4 3 1 0
5 4 1 0
6 5 1 0
1 6 2 0
6 7 1 0
7 8 1 0
9 8 2 0
1 9 1 0
10 9 1 0
11 10 2 0
12 11 1 0
13 12 2 0
14 13 1 0
15 14 2 0
10 15 1 0
13 16 1 0
4 17 2 0
3 18 1 0
18 19 1 0
20 19 2 0
21 20 1 0
22 21 2 0
23 22 1 0
24 23 2 0
19 24 1 0
2 25 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 384.91 | Molecular Weight (Monoisotopic): 384.0158 | AlogP: 5.49 | #Rotatable Bonds: 3 |
Polar Surface Area: 37.79 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 6.95 | CX Basic pKa: ┄ | CX LogP: 6.43 | CX LogD: 5.91 |
Aromatic Rings: 4 | Heavy Atoms: 25 | QED Weighted: 0.47 | Np Likeness Score: -1.66 |
References
1. (2017) Arf6 inhibitors and methods of synthesis and use thereof, |